INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $757,774 | -9.5% | 23,965 | +16.8% | 0.00% | 0.0% |
| Q2 2023 | $837,009 | +13.4% | 20,525 | +3.6% | 0.00% | 0.0% |
| Q1 2023 | $738,096 | +6.7% | 19,804 | -0.2% | 0.00% | 0.0% |
| Q4 2022 | $692,043 | -33.4% | 19,835 | +6.7% | 0.00% | 0.0% |
| Q3 2022 | $1,039,000 | +14.4% | 18,582 | +5.9% | 0.00% | 0.0% |
| Q2 2022 | $908,000 | -51.3% | 17,547 | -31.6% | 0.00% | 0.0% |
| Q1 2022 | $1,865,000 | -44.4% | 25,670 | -9.5% | 0.00% | -50.0% |
| Q4 2021 | $3,355,000 | -79.4% | 28,375 | -76.6% | 0.00% | -81.8% |
| Q3 2021 | $16,289,000 | -12.2% | 121,428 | +6.0% | 0.01% | -8.3% |
| Q2 2021 | $18,556,000 | +825.5% | 114,605 | +358.8% | 0.01% | +1100.0% |
| Q1 2021 | $2,005,000 | +48.5% | 24,981 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $1,350,000 | +516.4% | 24,824 | +137.8% | 0.00% | – |
| Q2 2020 | $219,000 | – | 10,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |